Dalrada (DFCO) Removes Shell Company Status.

LIVE QUOTE SAN DIEGO, Nov. 6, 2020 SAN DIEGO , Nov. 6,...
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Hapbee, Biotech Stock Review

Hapbee Technologies (HAPB): Updates and News Archive.

Recent Headlines UPDATED CONTINUOUSLY. June 4, 2021: Hapbee (HAPBF) Selects Accomplished...
Hapbee, Biotech Stock Review

Hapbee (HAPB) Soars 136% the First Day of Trading!

LIVE QUOTE Subscribe here for upcoming report.
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
Dalarada Health, Biotech Stock Review

Dalrada Cervical Cancer Testing Kit Study.

KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
Issam Radd

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

2021 and 2020 Milestones In Plain Sight. Locked and Loaded for most of 2020 - many major milestone...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...